Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.96 USD | +2.17% |
|
+21.75% | -35.22% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 435M |
---|---|---|---|---|---|
Net income 2024 * | -73M | Net income 2025 * | -91M | EV / Sales 2024 * | - |
Net cash position 2024 * | 311M | Net cash position 2025 * | 430M | EV / Sales 2025 * | 0.53 x |
P/E ratio 2024 * |
-5.68
x | P/E ratio 2025 * |
-5.31
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | +2.17% | ||
1 week | +21.75% | ||
Current month | +23.17% | ||
1 month | +17.61% | ||
3 months | -59.35% | ||
6 months | -11.20% | ||
Current year | -35.22% |
![Extreme 13.24](/images/extremecours_fleche.png)
![Extreme 12.98](/images/extremecours_fleche.png)
![Extreme 12.98](/images/extremecours_fleche.png)
![Extreme 9.18](/images/extremecours_fleche.png)
![Extreme 9.18](/images/extremecours_fleche.png)
![Extreme 9.18](/images/extremecours_fleche.png)
![Extreme 9.18](/images/extremecours_fleche.png)
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +5.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 16.96 | +2.17% | 174,882 |
24-06-13 | 16.6 | +2.53% | 197,022 |
24-06-12 | 16.19 | +3.65% | 308,392 |
24-06-11 | 15.62 | +2.76% | 146,144 |
24-06-10 | 15.2 | +9.12% | 923,112 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.22% | 435M | |
+18.15% | 124B | |
+18.02% | 112B | |
-12.75% | 22.22B | |
+5.07% | 22.94B | |
-39.94% | 16.87B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- TRML Stock